Skip to main content

Alemtuzumab News

FDA Medwatch Alert: FDA Warns About Rare But Serious Risks of Stroke and Blood Vessel Wall Tears with Multiple Sclerosis Drug Lemtrada (alemtuzumab)

The U.S. Food and Drug Administration (FDA) is warning that rare but serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Lymphocytic Leukemia (CLL), Multiple Sclerosis, Rheumatoid Arthritis

Alemtuzumab patient information at Drugs.com